Instrument Business Outlook: Volume 28 — Issue 15
15 Nov 2019
Categories:
Instrument Business Outlook
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
Content includes:
- Market Data
- Interviews and Analysis
- Special Features (Market Forecasts, M&A Analysis, Executive Compensation Table, Surveys, etc.)
- Company Financial Results
- Product Developments
- Regional and Industry Opportunities
Content includes:
- Market Data
- Interviews and Analysis
- Special Features (Market Forecasts, M&A Analysis, Executive Compensation Table, Surveys, etc.)
- Company Financial Results
- Product Developments
- Regional and Industry Opportunities
Table of Contents
-
IBO Fall 2019 Business Climate Review: US-China Trade Looms Large
- China-US Trade’s Threatening Instability
- The Challenges of Brexit
- IT Blossoms
- Market-based Concerns
- The M&A Way
- Opportunities Abound
- Employment Concerns
- AMP 2019 Highlights: Faster Cancer Detection, Improved Treatment Selection and More Efficient Workflows
-
Executive Briefing
- QIAGEN Considers Strategic Alternatives
- Abcam Adds to Conjugation and Protein Labeling Portfolio
- Gyros Protein Technologies Sold
- Hitachi Focuses on Electron Microscopy for Gene Therapy
- Horizon Discovery to Sell Animal Model Business
-
Third Quarter Results: Bruker, Danaher, Illumina, PerkinElmer, Thermo Fisher Scientific and Waters
- Bruker’s Semiconductor Metrology Products Continue to Experience Declining Sales
- Danaher’s European Sales Decline Due to Life Sciences and Environmental & Applied Solutions Demand
- Sales of Illumina Sequencing Consumables Surpass the $500 Million Mark
- Sluggish Sales for PerkinElmer’s Applied Market and Diagnostic Business Does Not Deter Company’s Positive Outlook for the Year
- Thermo Fisher Revenues Solid Despite Divestment of its Anatomical Pathology Business
- Unexpected Sales Decline from US Pharmaceutical Customers Impact Waters’ Quarterly Sales
-
Market Profile: Electron Spin Resonance/Electron Paramagnetic Resonance (ESR/EPR)
- Leading Vendors
- Largest Markets
- Instrument Cost
-
Industry Watch
- Government
- Energy
- Forensics
-
Region Watch
- South Africa
- China
- Hungary
-
News
-
Broad-based Companies
- Company Announcements
- Sales and Orders of Note
-
Sequencing
- Company Announcement
- Product Introductions
- Sales and Orders of Note
-
MS & LC/MS
- Company Announcements
- Product Introductions
- Sales and Orders of Note
-
Bioprocess Analysis
- Company Announcements
- Product Introductions
- Sales and Order of Note
-
Process Analysis
- Company Announcements
- Product Introductions
-
Broad-based Companies
- Bottom Line